您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8473 处方药 8099 非处方药 268 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 香港药房
产地国家: 香港
所属类别: 皮肤科药物->抗真菌类药物
处方药:处方药
包装规格: 15克/支
计价单位:
  点击放大  
生产厂家中文参考译名:
先灵葆雅
生产厂家英文名:
Schering-Plough
该药品相关信息网址1:
http://www.schering-plough.com/
原产地英文商品名:
Quadriderm Cream 15g/piece
原产地英文药品名:
BETAMETHASONE/CLIOQUINOL/GENTAMICIN/TOLNAFTATE
中文参考商品译名:
可立净软膏 15克/支
中文参考药品译名:
倍他米松/氯碘羟喹/庆大霉素/托萘酯
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
Purulent skin disease, sore pus cells
英文适应病症2:
Folliculitis, infectious eczematous dermatitis
英文适应病症3:
Hand ringworm, tinea pedis, tinea corporis, tinea corporis
英文适应病症4:
Acute eczematous dermatitis
英文适应病症5:
Fungal, bacterial infection of the skin Mixed
临床试验期:
完成
中文适应病症参考翻译1:
化脓性皮肤病、脓胞疮
中文适应病症参考翻译2:
毛囊炎、传染性湿疹样皮炎
中文适应病症参考翻译3:
手癣、足癣、体癣、股癣
中文适应病症参考翻译4:
急性湿疹样皮炎
中文适应病症参考翻译5:
真菌、细菌混合感染的皮肤病
药品信息:

---------------------------------------------------------------
部分中文Quadriderm Cream处方资料(仅供参考)
---------------------------------------------------------------

Quadriderm Cream编号:HK-10557

BETAMETHASONE:倍他米松,其结构式: 属高效含卤皮质激素类药物,作用于糖代谢,能减轻机体组织对损害性刺激所产生的病理变化,且疗效高、其抗炎作用比地塞米松强,副作用小,可治疗红斑狼疮、风湿性关节炎、哮喘等重病在国际临床被广泛应用。

GENTAMICIN:庆大霉素是一种氨基糖苷类抗生素, 主要用于治疗细菌感染,尤其是革兰氏阴性菌引起的感染。庆大霉素能与细菌核糖体30s亚基结合,阻断细菌蛋白质合成。庆大霉素是为数不多的热稳定性的抗生素,因而广泛应用于培养基配置。

CLIOQUINOL:氯碘羟喹,药品类别:皮肤科用药;适应症:化脓性皮肤病、脓胞疮、毛囊炎、传染性湿疹样皮炎、手癣、足癣、体癣、股癣、急性湿疹样皮炎、真菌、细菌混合感染的皮肤病。

TOLNAFTATE:药物名称:发癣退;别名:杀癣灵,癣退,发癣退;适应症:局部抗真菌药,用于浅表皮肤真菌感染,包括体癣、股癣、手足癣、花斑癣,但对毛发部及指甲的真菌感染无效。

Quadriderm Cream
Brand names: Quadriderm Cream
Generic name: Betamethasone
Manufacturer: Schering-Plough

Quadriderm Cream
For Dermatological use only

Description:
Each gram of Quadriderm Cream contains:
Betamethasone (as valerate) 0.5 mg (0.05%)
Gentamicin (as sulfate) 1 mg (0.1% )
Tolnaftate 10 mg (1.0%)
Clioquinol 10 mg (1.0%)
In a paraben and lanolin free water washable cream base containing 0.1% chlorocresol as a preservative.
Inactive ingredients: chlorocresol, ceteth 20, cetostearyl alcohol, white petrolatum, mineral oil and
sodium phosphate monobasic monohydrate.

ACTIONS:
Quadriderm Cream combines the anti-inflammatory, anti-pruritic and vasoconstrictive agent betamethasone valerate, the wide spectrum antibiotic gentamicin sulfate, the fungicidal agent tolnaftate and clioquinol, an antibacterial and antifungal agent.

INDICATIONS:
Quadriderm Cream is indicated for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infection caused by organisms sensitive to the components of this dermatologic preparation. Such disorders include inguinal dermatosis, eczematoid dermatitis, contact dermatitis, microbial, dermatitis, follicular dermatitis, parakeratosis, anal pruritus, seborrheic eczema, intertrigo, seborrheic dermatitis, impetigo, zona occipital, lichenified inguinal dermatophytosis and tinea infections such as tinea pedis, tinea cruris and tinea corporis

DOSAGE AND ADMINISTRATION:
 A thin film of Quadriderm Cream should be applied to cover completely the affected area two or three times daily, or as prescribed by the physician. Frequency of application should be determined according to severity of the condition.

Duration of therapy should be determined by patient response. In cases of tinea pedis longer therapy (2-4 weeks) may be necessary.

ADVERSE REACTIONS:
Local adverse reactions reported with the use of topical corticosteroids, especially, under occlusive dressings, include: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Rash, irritation and hypersensitivity have been reported with the topical usage of gentamicin sulfate, clioquinol and rarely with tolnaftate.

CONTRAINDICATIONS:
Quadriderm Cream is contraindicated in those patients with a history of sensitivity reactions to any of its components.

PRECAUTIONS:
Any of the side effects that are reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children.

Systemic absorption of topical steroids will be increased if extensive body surface areas are treated or if the occlusive technique is used. Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children.

Systemic absorption of topically applied gentamicin may be increased if extensive body surface area are treated, especially over prolonged time periods or in the presence of dermal disruption. In these cases, the undesirable effects which occur following systemic use of gentamicin may potentially occur. Caution use is recommended under these conditions, particularly in infants and children.

Prolonged use of topical antibiotics occasionally may result in overgrowth of non-susceptable organisms. If this occurs, or if irritation, sensitization or superinfection develops, treatment with Quadriderm Cream should be discontinued and appropriate therapy instituted.

Systemic absorption of clioquinol may interfere with thyroid function tests.

The ferric chloride test for phenylketonuria can yield a false-positive result if clioquinol is present in the urine. Slight staining of linens or clothing due to clioquinol may occur.

Quadriderm cream is not for ophthalmic use.

PEDIATRIC USE:
Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a large skin surface area to body weight ratio.

HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma Cortisol levels and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include a bulging fontanelle, headaches and bilateral papilledema.

USE DURING PREGNANCY AND IN NURSING WOMEN:
Since safety of topical corticosteroid use in pregnant women has not been established, drugs of this class should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in pregnant patients.

Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

OVERDOSE:
Symptoms: Excessive or prolonged use of topical corticosteroids can suppress pituitary-adrenal function, resulting in secondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's disease. A single overdose of gentamicin would not be expected to produce symptoms.

Excessive or prolonged use of topical antibiotics may lead to overgrowth of lesions by nonsusceptible organisms. Systemically, tolnaftate is pharmacologically inactive. Clioquinol rarely produces iodism.

Treatment:
Appropriate symptomatic treatment is indicated. Acute hypercorticoid symptoms are usually reversible. Treat electrolyte imbalance, if necessary. In case of chronic toxicity, slow withdrawal of corticosteroid is advised. If overgrowth by non-susceptible organisms occurs, stop treatment with Quadriderm Cream and institute appropriate therapy.

STORAGE:
Store below 25°C

---------------------------------------------------------------

于2010年5月19日更新

更新日期: 2010-5-19
附件:




 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com